WO2022000053A1 - Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition - Google Patents
Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition Download PDFInfo
- Publication number
- WO2022000053A1 WO2022000053A1 PCT/BR2020/050236 BR2020050236W WO2022000053A1 WO 2022000053 A1 WO2022000053 A1 WO 2022000053A1 BR 2020050236 W BR2020050236 W BR 2020050236W WO 2022000053 A1 WO2022000053 A1 WO 2022000053A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- mixtures
- total weight
- cosmetic sunscreen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 179
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 89
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 89
- 239000002537 cosmetic Substances 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 239000004904 UV filter Substances 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 230000001153 anti-wrinkle effect Effects 0.000 claims abstract description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000004615 ingredient Substances 0.000 claims description 27
- 239000004408 titanium dioxide Substances 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 11
- 239000012071 phase Substances 0.000 claims description 11
- 230000037072 sun protection Effects 0.000 claims description 11
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 239000000049 pigment Substances 0.000 claims description 10
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 9
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 9
- 229960005193 avobenzone Drugs 0.000 claims description 9
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 claims description 9
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 claims description 9
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 9
- 229960000601 octocrylene Drugs 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 claims description 8
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 claims description 8
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 8
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 229940106025 phenylethyl resorcinol Drugs 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 229940104261 taurate Drugs 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 8
- 239000000230 xanthan gum Substances 0.000 claims description 8
- 229940082509 xanthan gum Drugs 0.000 claims description 8
- 235000010493 xanthan gum Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 6
- 235000013980 iron oxide Nutrition 0.000 claims description 6
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 229960003966 nicotinamide Drugs 0.000 claims description 6
- 235000005152 nicotinamide Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 5
- 229940114124 ferulic acid Drugs 0.000 claims description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 5
- 235000001785 ferulic acid Nutrition 0.000 claims description 5
- 230000003711 photoprotective effect Effects 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 238000006386 neutralization reaction Methods 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000002304 perfume Substances 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 150000003839 salts Chemical class 0.000 description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 239000000377 silicon dioxide Substances 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 4
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical class OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 4
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 229960004502 levodopa Drugs 0.000 description 4
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 230000008845 photoaging Effects 0.000 description 4
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 4
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 3
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- WMJBVALTYVXGHW-UHFFFAOYSA-N 3,3-diphenylprop-2-enoic acid Chemical class C=1C=CC=CC=1C(=CC(=O)O)C1=CC=CC=C1 WMJBVALTYVXGHW-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 229920002517 Poloxamer 338 Polymers 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000008366 benzophenones Chemical class 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- 150000002462 imidazolines Chemical class 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Chemical class 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 229940100460 peg-100 stearate Drugs 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 150000003918 triazines Chemical class 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- CENPSTJGQOQKKW-UHFFFAOYSA-N 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=CC=C(C=2N=C(N=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 CENPSTJGQOQKKW-UHFFFAOYSA-N 0.000 description 2
- UWNADWZGEHDQAB-UHFFFAOYSA-N 2,5-dimethylhexane Chemical group CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- BVNWQSXXRMNYKH-UHFFFAOYSA-N 4-phenyl-2h-benzotriazole Chemical class C1=CC=CC=C1C1=CC=CC2=C1NN=N2 BVNWQSXXRMNYKH-UHFFFAOYSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical class CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010040829 Skin discolouration Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 230000037338 UVA radiation Effects 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 208000002440 photoallergic dermatitis Diseases 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- -1 polysiloxane groups Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 230000037370 skin discoloration Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052712 strontium Chemical class 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 229960000368 sulisobenzone Drugs 0.000 description 2
- 230000008833 sun damage Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- GJUXFTUISAQMQE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)C(=O)OCC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 GJUXFTUISAQMQE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 description 1
- ZVIJJZZVZCQINB-UHFFFAOYSA-N 6-n-(2-ethylhexyl)-2-n,4-n-bis[4-[5-(2-methylbutan-2-yl)-1,3-benzoxazol-2-yl]phenyl]-1,3,5-triazine-2,4,6-triamine Chemical compound CCC(C)(C)C1=CC=C2OC(C3=CC=C(C=C3)NC=3N=C(NC=4C=CC(=CC=4)C=4OC5=CC=C(C=C5N=4)C(C)(C)CC)N=C(N=3)NCC(CC)CCCC)=NC2=C1 ZVIJJZZVZCQINB-UHFFFAOYSA-N 0.000 description 1
- KHNVQXPXLJIGFS-UHFFFAOYSA-N 7-[(6-hydroxy-5-phenyl-2H-benzotriazol-4-yl)methyl]-6-phenyl-2H-benzotriazol-5-ol Chemical class C=1C=CC=CC=1C=1C(O)=CC=2NN=NC=2C=1CC(C=1N=NNC=1C=C1O)=C1C1=CC=CC=C1 KHNVQXPXLJIGFS-UHFFFAOYSA-N 0.000 description 1
- BIQUJLSTLXZGTO-UHFFFAOYSA-N C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC Chemical compound C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC BIQUJLSTLXZGTO-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical class NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Chemical class 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 229960003055 bisoctrizole Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229940115478 isopropyl lauroyl sarcosinate Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical class [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- PVWXTVUZGJXFJQ-CCEZHUSRSA-N methyl (E)-4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(\C(C)C)=C(/C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-CCEZHUSRSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- XLCIFRJORZNGEV-UHFFFAOYSA-N propan-2-yl 2-[dodecanoyl(methyl)amino]acetate Chemical compound CCCCCCCCCCCC(=O)N(C)CC(=O)OC(C)C XLCIFRJORZNGEV-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- UKSFMDODPANKJI-UHFFFAOYSA-M sodium;2-[methyl(octadecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O UKSFMDODPANKJI-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical group [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Definitions
- COSMETIC SUNSCREEN COMPOSITION USE OF A COSMETIC SUNSCREEN COMPOSITION, AND PROCESSES FOR MANUFACTURING A COSMETIC
- the present invention is directed to new cosmetic sunscreen compositions with high Sun Protection Factor (SPF), antiwrinkles and anti-spots efficacy, which may or may not tint the skin, comprising at least one UV filter, at least one active compound and at least one polymer.
- SPF Sun Protection Factor
- the present invention is also directed to the use of a cosmetic sunscreen composition, and to a process for manufacturing a cosmetic sunscreen composition.
- UVA/UVB cosmetic sunscreen compositions used to accomplish photoprotection, namely, inorganic UV filters and organic UV filters.
- the mechanism of melanogenesis that is, the mechanism of melanin formation is particularly complex, and schematically involves the following main steps:
- Tyrosine is involved in the mechanism of skin pigmentation, which schematically involves the following main steps:
- Tyrosinase is the essential enzyme involved in these reactions. In particular, it catalyzes the conversion reaction of tyrosine to DOPA (dihydroxyphenylalanine) thanks to its hydroxylase activity, and the conversion reaction of DOPA to dopaquinone by virtue of its oxidase activity. This tyrosinase only acts when it is maturing under the influence of certain biological factors.
- DOPA dihydroxyphenylalanine
- UVA radiation can have a significant contribution to the clinical consequences of solar UV exposure, particularly the pigmentation caused by the solar radiation.
- UVA induces immediate pigment darkening (IPD) within a short time, as little as a few hours, by acting on preexisting melanin. UVA can also cause persistent pigment darkening (PPD) in the skin. Among the UV wavelengths reaching the Earth surface, longwave UVA (340- 400nm) represents up to 80% of total UV and show high penetration properties, reaching the deep dermis.
- IPD immediate pigment darkening
- PPD persistent pigment darkening
- UVA reaches the dermal layers of the skin and its effects on photo aging and keratinocyte invasiveness, melanocytes seem to be more susceptible to the damaging effects of UVA. For example, exposure of cultured melanocytes and keratinocytes from the same donor to UVA and UVB showed that UVA-induced oxidative lesions contributed to a larger extent to DNA damage in melanocytes than in keratinocytes.
- the degree of UV protection afforded by a cosmetic sunscreen composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection (UVA/UVB).
- cosmetic sunscreen compositions must provide good protection against the sun, a measure of which is the Sun Protection Factor (SPF) value, yet have satisfactory sensory perception, such as a smooth but not greasy feel upon application.
- SPF Sun Protection Factor
- sunscreen filters are oil-like and/or oil-soluble materials. High levels of sunscreen filters in sunscreen products render the products less appealing for their greasy skin feel, stickiness, long drying time, and leave shiny residue on the skin after application. The filters also have the tendency to whiten the skin after application and after becoming wet with water or perspiration which is an undesirable attribute.
- an important problem of cosmetic sunscreen compositions is that due to the great amount of sunscreen filters associated with great amount of fillers to ensure the good sensoriality and pigments in the O/W emulsion, it tends to be unstable.
- a cosmetic sunscreen composition that not only confers photoprotection of keratinous materials, but also provides additional properties.
- a cosmetic sunscreen composition with high SPF, antiwrinkles and anti-spots efficacy, which may or may not be able to tint the skin is desired, which is stable and does not feel heavy on the consumer’s skin.
- the inventors of the present application have surprisingly managed to develop a cosmetic sunscreen composition with high SPF, antiwrinkles and anti-spots efficacy, which may or may not be able to tint the skin, while the formula had good sensorial attributes and stability.
- the present invention is directed to new cosmetic sunscreen compositions with high SPF, antiwrinkles and anti-spots efficacy, which may or may not tint the skin, comprising at least one UV filter, at least one active compound and at least one polymer.
- the present invention is also directed to the use of a cosmetic sunscreen composition, and to a process for manufacturing a cosmetic sunscreen composition.
- the cosmetic sunscreen composition of the present invention comprises:
- UV filter selected from octocrylene, terephthalylidene dicamphor sulfonic acid, butyl methoxydibenzoylmethane, drometrizole trisiloxane, ethylhexyl triazone and mixtures thereof;
- the amount of the at least one UV filter ranges from about 5.0 to about 20.0 %, from about 6.0 to about 19.0 %, from about 7.0 to about 18.0 %, from about 8.0 to about 17.0 %, from about 9.0 to about 16.0 %, from about 10.0 to about 17.0%, from about 10.0 to about 15.0 %, from about 11 .0 to about 14.0 %, from about 12.0 to about 15.0 %, from about 14.0 to about 17.0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition.
- the amount of the at least one active compound ranges from about 0.1 to about 10.0 %, from about 0.5 to about 10.0 %, from about 0.75 to about 9.0 %, from about 1 .0 to 7.5 %, from about 2.0 to about 8.0 %, from about 2.5 to about 6.0 %, from about 4.0 to about 5.0 %, from about 0.8 to about 5.0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition.
- the amount of the at least one polymer ranges from about 1 .5 to about 5.0 %, from about 2.0 to about 4.5 %, from about 2.5 to about 4.0 % by weight, from about 3.0 to about 3.5 %, including all ranges and sub ranges there between, based on the total weight of the composition.
- the cosmetic sunscreen composition of the present invention further comprises from about 5.0 to about 15.0 %, preferably from about 6.0 to about 14.0 %, from about 7.0 to about 13.0 %, from about 8.0 to about 12.0 %, from about 9.0 to about 11 .0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition, of at least one pigment selected from titanium dioxide, iron oxides, and mixtures thereof.
- the cosmetic sunscreen composition of the present invention further comprises cosmetically acceptable ingredients selected from perfume/fragrance, polymers, preserving agents, solvents, additional actives, surfactants, fat materials, vitamins, fillers and mixtures thereof.
- the cosmetic sunscreen composition of the present invention presents a Sun Protection Factor (SPF) ranging from 30 to 80, preferably from 40 to 70, more preferably about 50.
- SPF Sun Protection Factor
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65, 70 and 80.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 50.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 60.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 70.
- the cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 80.
- the cosmetic sunscreen composition of the present invention is in the form of an oil in water (O/W) emulsion.
- the cosmetic sunscreen composition of the present invention can be used as a daily product for the skin.
- the present invention also relates to the use of said cosmetic sunscreen composition for manufacturing a product for the photoprotection of keratinous materials with high SPF, antiwrinkles and anti-spots efficacy.
- the expression “at least” means one or more and thus includes individual components as well as mixtures/combinations.
- anti-spots relates to the brightening of pigmented spots or melasma (skin discoloration) for an even-toned skin. Synonyms may include “skin bleaching”, “depigmentation”, “skin tone correction”, among others.
- ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges.
- a range from 1 -5 includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc.
- All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
- compositions and methods of the present disclosure can comprise, consist of, or consist essentially of the essential elements and limitations of the disclosure described herein, as well as any additional or optional ingredients, components, or limitations described herein or otherwise useful.
- the expression “at least one” is interchangeable with the expression “one or more” and thus includes individual components as well as mixtures/combinations.
- a “an,” and “the” are understood to encompass the plural as well as the singular.
- the term “a mixture thereof” also relates to “mixtures thereof.”
- the term “a mixture thereof” is used, following a list of elements as shown in the following example where letters A-F represent the elements: “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture thereof.”
- the term, “a mixture thereof does not require that the mixture include all of A, B, C, D, E, and F (although all of A, B, C, D, E, and F may be included). Rather, it indicates that a mixture of any two or more of A, B, C, D, E, and F can be included. In other words, it is equivalent to the phrase “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture of any two or more of A, B, C, D, E, and F.”
- “Substituted,” as used herein, means comprising at least one substituent.
- substituents include atoms, such as oxygen atoms and nitrogen atoms, as well as functional groups, such as hydroxyl groups, ether groups, alkoxy groups, acyloxyalkyl groups, oxyalkylene groups, polyoxyalkylene groups, carboxylic acid groups, amine groups, acylamino groups, amide groups, halogen containing groups, ester groups, thiol groups, sulphonate groups, thiosulphate groups, siloxane groups, and polysiloxane groups.
- the substituent(s) may be further substituted.
- a salt thereof also relates to “salts thereof.”
- the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A,
- B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included, or a mixture of any two of A, B,
- C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.
- the salts referred to throughout the disclosure may include salts having a counter-ion such as an alkali metal, alkaline earth metal, or ammonium counter-ion. This list of counter-ions, however, is non-limiting.
- compositions of the instant disclosure can be free or essentially free of all components and elements positively recited throughout the instant disclosure.
- the cosmetic sunscreen composition of the present invention may further comprise additional UV filters.
- the concentration of additional sunscreen/UV filters in the system may be between about 5 % to about 35 %, preferably between about 7 % to about 30 % and even more preferably between about 10 % to about 29 % by weight of the total weight of the composition.
- Additional non-limiting suitable UV filters of the present invention could be as follows:
- oil-soluble organic sunscreen ingredient means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
- Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP893119; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as
- cinnamic derivatives include, but are not limited to, ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
- Dibenzoylmethane derivatives examples include, but are not limited to, isopropyl dibenzoylmethane.
- suitable salicylic derivatives include, but are not limited to, homosalate, ethylhexyl salicylate, dipropylene glycol salicylate and TEA salicylate.
- Beta, beta -Diphenylacrylate derivatives
- beta, beta -diphenylacrylate derivatives examples include, but are not limited to, etocrylene.
- benzophenone derivatives include, but are not limited to, benzophenone-1 , benzophenone-2, benzophenone-3 or oxybenzone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, n-hexyl 2-(4-diethylamino-2- hydroxybenzoyl)benzoate or as a mixture with octyl methoxycinnamate.
- Suitable benzylidenecamphor derivatives include, but are not limited to, 3-benzylidene camphor manufactured, 4-methylbenzylidene camphor, polyacrylamidomethyl benzylidene camphor manufactured.
- Suitable phenylbenzotriazole derivatives include, but are not limited to, methylene bis-benzotriazolyl tetramethylbutyl-phenol, or in micronized form as an aqueous dispersion.
- triazine derivatives include, but are not limited to, bis-ethylhexyloxyphenol methoxyphenyl triazine, diethylhexyl butamido triazone, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s-triazine, 2,4,6-tris(diisobutyl 4’- aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'-aminobenzalmalonate)-6-(n- butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents described in patent US 6,225,467, patent application WO 2004/085412 (see compounds 6 and 9) or the document "Symmetrical Triazine Derivatives" IP.COM Journal, IP.COM Inc., West Henrietta, NY, US (20 September 2004), especially 2,4,6-tris(
- An example of a suitable anthranilic derivative includes, but is not limited to, methyl anthranilate.
- An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
- benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15.
- An example of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
- benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl) imino-1 ,3,5-triazine, and mixtures thereof.
- the oil-soluble organic sunscreen ingredient will be chosen from ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
- the oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
- the “water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
- Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, phenylbenzimidazole sulfonic acid, benzophenone-4, aminobenzoic acid (PABA), 4-Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated by reference; and cinnamido amine cationic quaternary salts and derivatives such as those described in United
- the salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminum, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2- hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2-hydroxyethyl)amine; lysine or arginine salts.
- Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used.
- the sodium salt is preferably used.
- the water-soluble organic sunscreen ingredient will be chosen from methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
- the water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1% to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1% to about 7% by weight, based on the total weight of the composition.
- the “silica-coated titanium dioxide sunscreen ingredient” means spherical beads which are formed by encapsulating titanium dioxide particles in silica.
- Non-limiting examples of silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica: titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
- silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica: titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
- the silica-coated titanium dioxide sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 1% to about 10% by weight, preferably in an amount of from about 2% to about 10% by weight, and most preferably about 5% to about 10% by weight, based on the total weight of the composition.
- the cosmetic sunscreen composition of the present invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, polymers, pigments and mixtures thereof.
- the cosmetic sunscreen composition of the present invention comprises water.
- the water used may be sterile demineralized water and/or deionized water and/or a floral water such as rose water, cornflower water, chamomile water or lime water, and/or a natural thermal or mineral water such as, for example: water from Vittel, water from the Vichy basin, water from Uriage, water from La Roche Posay, water from La Bourboule, water from Enghien-les-Bains, water from Saint Gervais-les-Bains, water from Neris-les-Bains, water from Allevar-les-Bains, water from Digne, water from Maizieres, water from Neyrac-les-Bains, water from Lons-le-Saunier, water from EauxBonnes, water from Rochefort, water from Saint Christau, water from Les Fumades, water from Tercis-les-Bains or water from Avene.
- Water may also comprise reconstituted thermal water, that is to say a water comprising trace elements such as
- Suitable polymers include, but are not limited to, acrylates/Cio-3o alkyl acrylate crosspolymer, styrene/acrylates copolymer, and mixtures thereof.
- the composition may also comprise at least one silicon ingredient, which may be dimethicone and caprylyl methicone, among others.
- Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
- Additional suitable solvents include, but are not limited to, C12-15 alkyl benzoate, pentylene glycol, caprylyl glycol, and mixtures thereof.
- Adequate surfactants may be selected from potassium cetyl phosphate, sodium methyl stearoyl taurate and inulin lauryl carbamate, among others.
- the solvent is present in a concentration from about 15 to 100% by weight, or from about 25 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 40 to about 60% by weight, including ranges and sub-ranges therebetween, based on the total weight of the combinations and/or compositions of the present disclosure.
- Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
- the composition may comprise at least one dye/pigment, preferably titanium oxide or iron oxides.
- Exemplary fat or oil materials include, but are not limited to, isopropyl lauroyl sarcosinate, stearyl alcohol, and mixtures thereof.
- the composition may also comprise at least one filler, such as silica or polylactic acid.
- the additional ingredients may represent from 50% to 85%, such as from 55% to 82% or such as from 60 to 80% by weight of the total weight of the composition.
- a non-limiting example regarding the preparation of the cosmetic sunscreen composition according to the present invention could be as follows:
- An example of a suitable cosmetic sunscreen composition according to the present invention comprises:
- Another suitable cosmetic sunscreen composition according to the present invention comprises:
- additional cosmetically acceptable ingredients such as vitamins, fillers, fatty compounds, fragrances, triethanolamine and disodium EDTA;
- An additional suitable cosmetic sunscreen composition according to the present invention comprises:
- Example 1 A suitable composition according to the state of the art is as Example 1 and a suitable cosmetic sunscreen composition according to the present invention is as Examples 2 to 5, as follows:
- the product was used during 28 days by the 50 adults, with all phototypes, with 2 visits (first day, DO and last day, D28). Each subject was her/his own control (comparison between before and after application).
- the application of the cosmetic sunscreen composition of the present invention was performed by the subjects themselves, according to instructions provided by the team and presented on the subject’s diary.
- composition according to Example 3 is cutaneous safe.
- the product has a light texture, has pleasant texture, does not leave the skin shiny, does not leave the skin oily, is quickly absorbed, does not leave the skin sticky, makes the skin more radiant/luminous, disguises the visible pores, gives a comfort touch, brightens the skin, the skin looks more uniform, leaves the skin softer, the skin feels more moisturized immediately after application, the skin feels moisturized throughout the day, the product plumps the skin, leaves the skin firmer, is easy to spread, does not clog pores and has a pleasant odor.
- the cosmetic sunscreen composition of the present invention according to Examples 2 and 3 and a control composition were applied to filter discs of a contact test (patch test) and then fixed on the right or left back (scapular area) of the volunteers, which was allowed to stay on the volunteer’s skin until removal by a trained professional and the area received ultraviolet irradiation A and B.
- Dermatological clinical evaluation was carried out at the beginning and at the end of the study and the volunteers were accompanied by a dermatologist throughout the research.
- the cosmetic sunscreen composition of the present invention was considered safe under the conditions evaluated.
- the cosmetic sunscreen compositions of the present invention according to Example 2 was applied on the subject's dry skin and irradiated with a controlled dose of ultraviolet radiation. Then, the cosmetic sunscreen composition of the present invention was applied to another site, and after a period of 40 minutes, during which the study subject remained in a bathtub, the irradiation was repeated. The sites were evaluated after a period of 16-24 hours.
- the mean static SPF of the cosmetic sunscreen composition of Example 3 was 62.0, and after immersion was 24.8.
- the cosmetic sunscreen composition of Example 2 demonstrated a PF-
- the cosmetic sunscreen compositions of the present invention according to Examples 2 to 5 had very good consumer results, with high approval in all evaluated criteria.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2020/050236 WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
KR1020237003080A KR20230029919A (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of cosmetic sunscreen composition, and method for preparing cosmetic sunscreen composition |
CN202080102545.7A CN116710054A (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition and method for producing a cosmetic sunscreen composition |
BR112022021113A BR112022021113A2 (en) | 2020-06-30 | 2020-06-30 | COSMETIC SUN PROTECTION COMPOSITION WITH HIGH SPF, USE OF A COSMETIC SUN PROTECTION COMPOSITION AND PROCESSES FOR MANUFACTURING A COSMETIC SUN PROTECTION COMPOSITION |
FR2008769A FR3111809B1 (en) | 2020-06-30 | 2020-08-28 | Photoprotective cosmetic composition, use of a photoprotective cosmetic composition and process for manufacturing a photoprotective cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2020/050236 WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022000053A1 true WO2022000053A1 (en) | 2022-01-06 |
Family
ID=71574899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2020/050236 WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR20230029919A (en) |
CN (1) | CN116710054A (en) |
BR (1) | BR112022021113A2 (en) |
FR (1) | FR3111809B1 (en) |
WO (1) | WO2022000053A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102664351B1 (en) * | 2023-05-23 | 2024-05-08 | 한국콜마주식회사 | Sun screening cosmetic composition comprising a sunscreen material composed of an organic-inorganic composite |
Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
US5601811A (en) | 1994-08-01 | 1997-02-11 | Croda, Inc. | Substantive water-soluble cationic UV-absorbing compounds |
GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
US5624663A (en) | 1987-08-28 | 1997-04-29 | L'oreal | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates |
EP0832642A2 (en) | 1996-09-13 | 1998-04-01 | 3V SIGMA S.p.A | Derivatives of Benzoxazole useful as uv filters |
DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
DE19746654A1 (en) | 1997-08-13 | 1999-02-18 | Basf Ag | Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds |
DE19755649A1 (en) | 1997-12-15 | 1999-06-17 | Basf Ag | Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics |
EP0967200A1 (en) | 1998-06-26 | 1999-12-29 | Basf Aktiengesellschaft | 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations |
DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
EP1008586A1 (en) | 1998-12-11 | 2000-06-14 | Basf Aktiengesellschaft | Oligomeric diarylbutadienes |
EP1027883A2 (en) | 1999-01-11 | 2000-08-16 | 3V SIGMA S.p.A | Combinations of sunscreen agents with UV-A and UV-B filtering properties |
US6225467B1 (en) | 2000-01-21 | 2001-05-01 | Xerox Corporation | Electroluminescent (EL) devices |
EP1133980A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations |
EP1133981A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations |
EP1300137A2 (en) | 2001-10-02 | 2003-04-09 | 3V SIGMA S.p.A | Combinations of sunscreens |
DE10162844A1 (en) | 2001-12-20 | 2003-07-03 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives |
WO2004006878A1 (en) | 2002-07-10 | 2004-01-22 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
WO2004085412A2 (en) | 2003-03-24 | 2004-10-07 | Ciba Specialty Chemicals Holding Inc. | Symmetrical triazine derivatives |
WO2005058269A1 (en) | 2003-12-17 | 2005-06-30 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
WO2006032741A1 (en) | 2004-09-20 | 2006-03-30 | L'oréal | Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter |
WO2006035007A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic light-block preparation made from micropigments |
WO2006035000A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Sun protection emulsion comprising a high fraction of sun protection filter pigments |
WO2006034991A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | W/o emulsion comprising uv filter pigments |
WO2006034985A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate |
WO2006034992A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic sunscreen emulsions containing organic micropigments |
WO2006034982A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Light-block concentrate with organic micropigments |
EP1990372A2 (en) | 2007-05-09 | 2008-11-12 | Ciba Holding Inc. | Water soluble UV filters |
WO2018000060A1 (en) * | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
WO2020000071A1 (en) * | 2018-06-29 | 2020-01-02 | L'oreal | Customized color shade sunscreen products |
WO2020024022A1 (en) * | 2018-07-31 | 2020-02-06 | L'oreal | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2939669B1 (en) * | 2008-12-17 | 2011-03-25 | Oreal | COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions. |
-
2020
- 2020-06-30 BR BR112022021113A patent/BR112022021113A2/en unknown
- 2020-06-30 WO PCT/BR2020/050236 patent/WO2022000053A1/en active Application Filing
- 2020-06-30 KR KR1020237003080A patent/KR20230029919A/en not_active Application Discontinuation
- 2020-06-30 CN CN202080102545.7A patent/CN116710054A/en active Pending
- 2020-08-28 FR FR2008769A patent/FR3111809B1/en active Active
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
US5624663A (en) | 1987-08-28 | 1997-04-29 | L'oreal | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates |
US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
US5601811A (en) | 1994-08-01 | 1997-02-11 | Croda, Inc. | Substantive water-soluble cationic UV-absorbing compounds |
GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
EP0832642A2 (en) | 1996-09-13 | 1998-04-01 | 3V SIGMA S.p.A | Derivatives of Benzoxazole useful as uv filters |
DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
DE19746654A1 (en) | 1997-08-13 | 1999-02-18 | Basf Ag | Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds |
DE19755649A1 (en) | 1997-12-15 | 1999-06-17 | Basf Ag | Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics |
EP0967200A1 (en) | 1998-06-26 | 1999-12-29 | Basf Aktiengesellschaft | 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations |
DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
EP1008586A1 (en) | 1998-12-11 | 2000-06-14 | Basf Aktiengesellschaft | Oligomeric diarylbutadienes |
EP1027883A2 (en) | 1999-01-11 | 2000-08-16 | 3V SIGMA S.p.A | Combinations of sunscreen agents with UV-A and UV-B filtering properties |
US6225467B1 (en) | 2000-01-21 | 2001-05-01 | Xerox Corporation | Electroluminescent (EL) devices |
EP1133980A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations |
EP1133981A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations |
EP1300137A2 (en) | 2001-10-02 | 2003-04-09 | 3V SIGMA S.p.A | Combinations of sunscreens |
DE10162844A1 (en) | 2001-12-20 | 2003-07-03 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives |
WO2004006878A1 (en) | 2002-07-10 | 2004-01-22 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
WO2004085412A2 (en) | 2003-03-24 | 2004-10-07 | Ciba Specialty Chemicals Holding Inc. | Symmetrical triazine derivatives |
WO2005058269A1 (en) | 2003-12-17 | 2005-06-30 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
WO2006032741A1 (en) | 2004-09-20 | 2006-03-30 | L'oréal | Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter |
WO2006035007A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic light-block preparation made from micropigments |
WO2006035000A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Sun protection emulsion comprising a high fraction of sun protection filter pigments |
WO2006034991A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | W/o emulsion comprising uv filter pigments |
WO2006034985A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate |
WO2006034992A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic sunscreen emulsions containing organic micropigments |
WO2006034982A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Light-block concentrate with organic micropigments |
EP1990372A2 (en) | 2007-05-09 | 2008-11-12 | Ciba Holding Inc. | Water soluble UV filters |
WO2018000060A1 (en) * | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
WO2020000071A1 (en) * | 2018-06-29 | 2020-01-02 | L'oreal | Customized color shade sunscreen products |
WO2020024022A1 (en) * | 2018-07-31 | 2020-02-06 | L'oreal | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition |
Non-Patent Citations (2)
Title |
---|
DATABASE GNPD [online] MINTEL; 15 February 2016 (2016-02-15), ANONYMOUS: "Clarify Coloured Gel-Cream SPF 60", XP055784832, retrieved from https://www.gnpd.com/sinatra/recordpage/3799751/ Database accession no. 3799751 * |
DATABASE GNPD [online] MINTEL; 20 March 2018 (2018-03-20), ANONYMOUS: "Intelligent Anti-Age DNA Defense SPF 100", XP055784849, retrieved from https://www.gnpd.com/sinatra/recordpage/5520865/ Database accession no. 5520865 * |
Also Published As
Publication number | Publication date |
---|---|
KR20230029919A (en) | 2023-03-03 |
CN116710054A (en) | 2023-09-05 |
BR112022021113A2 (en) | 2023-01-10 |
FR3111809A1 (en) | 2021-12-31 |
FR3111809B1 (en) | 2023-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019059791A (en) | Light protective compositions | |
EP1317918B1 (en) | Cosmetic sunscreen compositions based on synergistic filter mixture and their use | |
EP3873622A1 (en) | A liquid and transparent blend of uv filters | |
FR3001136A1 (en) | COSMETIC OR DERMATOLOGICAL EMULSION COMPRISING A MEROCYANINE AND AN EMULSIFIER SYSTEM CONTAINING AN AMPHIPHILIC POLYMER COMPRISING AT LEAST ONE ACRYLAMIDO 2-METHYLPROPANE SULFONIC ACIDIC PATTERN | |
US20240299280A1 (en) | Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition | |
EP2501359A1 (en) | A cosmetic or dermatological composition with low stickiness, containing a lipophilic active ingredient | |
JP6509743B2 (en) | Cosmetic or dermatological composition comprising a merocyanine, an organic UVB screening agent and an additional organic UVA screening agent | |
FR3073409B1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN ACRYLIC POLYMER. | |
KR20030047810A (en) | Screening composition comprising a screening agent of the dibenzoylmethane derivative type and an amino-substituted 2-hydroxybenzophenone derivative | |
US20240000677A1 (en) | Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition | |
CA2511078C (en) | Process of photostabilization of a derivative of dibenzoylmethane using an aryl-alkyl benzoate derivative and photoprotective cosmetic compositions | |
WO2022000053A1 (en) | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition | |
EP3829531B1 (en) | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition | |
KR20030047807A (en) | Screening composition comprising a 1,3,5-triazine derivative, a dibenzoylmethane derivative and an amino-substituted 2-hydroxybenzophenone derivative | |
CN114746070A (en) | Sunscreen compositions with multiple photoprotective UV filters | |
JP3893336B2 (en) | Shielding composition containing benzoylmethane derivative and 1,1,3-tris (2-methyl-4-hydroxy-5-tert-butylphenyl) butane | |
EP1323411A1 (en) | Cosmetic sunscreen compositions based on a synergic mixture of screening agents and their uses | |
JP2007204476A (en) | Cinnamic ester type uv-b screening agent, dibenzoylmethane type uv-a screening agent and composition containing s-triazine derivative; photostabilization method | |
JP6487337B2 (en) | Cosmetic or dermatological composition comprising merocyanine and insoluble organic UV screening agent and / or insoluble inorganic UV screening agent | |
FR3075050A1 (en) | COMPOSITION COMPRISING BAICALIN AND ANTIOXIDANT COMPOUND | |
EP1370231B1 (en) | Filtering composition containing a filter of the type derived from dibenzoylmethane and a 4,4-diarylbutadiene type filter | |
CN116056680A (en) | Cosmetic sunscreen composition, method for producing a cosmetic sunscreen composition and use of a cosmetic sunscreen composition | |
WO2022160020A1 (en) | Water-in-oil cosmetic sunscreen composition, use of a water-in-oil cosmetic sunscreen composition, and process for manufacturing a water-in-oil cosmetic sunscreen composition | |
EP1317919A1 (en) | Cosmetic sunscreen compositions based on synergistic filter mixture and their use | |
JP2004517095A (en) | Shielding compositions of the type derived from dibenzoylmethane and shielding compositions containing p-methyl-benzylidene camphor and diarylbutadiene compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20739248 Country of ref document: EP Kind code of ref document: A1 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022021113 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202080102545.7 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 112022021113 Country of ref document: BR Kind code of ref document: A2 Effective date: 20221018 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20739248 Country of ref document: EP Kind code of ref document: A1 |